Emergence of Enterococcus as a significant pathogen.
Moellering
R C
RC
Department of Medicine, New England Deaconess Hospital, Boston, Massachusetts 02215.
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology*; D004352:Drug Resistance, Microbial; D016983:Enterococcus / Q000145:classification / Q000187:drug effects / Q000472:pathogenicity*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D016920:Meningitis, Bacterial / Q000188:drug therapy / Q000382:microbiology; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000382:microbiology; D014774:Virulence
D000900:Anti-Bacterial Agents